Prof T. Tselios, born in Messolonghi Greece in January 1971. He obtained his diploma (Chemistry) in April 1994, PhD (Organic and medicinal Chmeistry) in October 2001 and MSc (Medicinal Chemistry) in July 2003 from the Department of Chemistry, University of Patras. He has joined, as a visiting scientist, Austin Research Institute, Melbourne Australia (2005 and 2013), School of Chemistry, University of Cardiff, UK (2006, 2008 and 2010) and University of Barcelona, Spain (2010). Research Activities: Organic, Peptide and Medicinal Chemistry. Rational design and synthesis of linear, cyclic peptide analogues and non-peptide mimetics. Structure Activity Relationship (SAR) studies. Conformational studies and Molecular Modelling of bioactive and pharmaceutical compounds. Interactions of bioactive molecules (docking studies). Pharmacophore analysis. Homology Modelling. Fellowships and Awards: 1998: Award from the “Leonidas Zervas” foundation, Athens, Greece; 2002-2003: Scholarship by the State Scholarship's Foundation of Greece; Brain Science, Open Access Journal, «Best Paper Award 2018», Title: Multiple Sclerosis: Immunopathology and Treatment Update; «Poster Prize» 32nd Cyprus-Noordwijkerhout-Camerino Symposium: “Trends in Drug Research” Limassol, Cyprus, 18-22 May 2014. Patents: “Peptide analogues of Myelin Basic Protein epitopes in the treatment of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)”. GPO AGIK 38/17, CO7K 14/47, 09/05/2002/USA; “Peptide Analogues and Conjugates Thereof”: PCT/IB2008/003493, WO 2009/066175; “Immunotherapy of Multiple Sclerosis Using Mannosylated Peptides as Therapeutic Vaccines”: PCT/IB2009/000382, WO 2009/093143. Guest Editor: Special Issue "Cyclic Peptide Analogues and Non-Peptide Mimetics” in Molecules, 2019-2020. Teaching Activities: 2005-today (Undergraduate teaching): Courses in the field of “Organic Chemistry” & laboratories of “Experimental Organic Chemistry” 2005-today (Graduate teaching): Courses in Medicinal Chemistry: “NMR Spectroscopy and Molecular Design” and laboratories of “Advanced Experimental Organic Chemistry” (MSc Program “Medicinal Chemistry”). Supervising of PhD / MSc theses & Postdoctoral fellows: 2006-today: Eight (8) PhD theses. 2005-today:Thirty (30) MSc theses. 2014-today: Dr Haralambos Tzoupis (Postdoctoral Fellow). 2015-2017: Dr Carmen Simal Fernandez (Postdoctoral Fellow). Member in Editorial Board: Journal of Molecular Graphics and Modelling; Molecules Reviewer of manuscripts in journals in the field of Organic and Medicinal Chemistry: Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, PLOS ONE, Journal of Molecular Graphics and Modelling, Journal of Combinatorial Chemistry, Journal of Drug Delivery, Bioinorganic Chemistry and Applications, Molecules, Journal of Computer Aided Molecular Design, Protein and Peptide Letters. Main Research Grands: 1) 2011-2015: (Collaborator) Greek General Secretariat of Research and Technology. Cooperation Program. Project title: “Pre-clinical and Toxicology Evaluation of Immunodominant Myelin Peptides/Mimetics Conjugated with Mannan towards Clinical Phase I-II Studies: A Potential Therapeutic Vaccine Drug in the Treatment of Multiple Sclerosis (MS)”. 2) 2014-2015: (Scientific Supervisor) Greece-Israel cooperation program, Greek General Secretariat of Research and Technology. Project Title: “A novel combined approach for the Immunotherapy of Multiple Sclerosis”. 3) 2018-2021: (Collaborator - Scientific Supervisor for the Department of Chemistry, University of Patras). Co‐financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH – CREATE - INNOVATE. Project Title: “Development of an advanced humanized mouse model for multiple sclerosis: application for pre-clinical studies and drug testing” 4) 2020-2023:(Scientific Supervisor) Co‐financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH – CREATE - INNOVATE.Project Title: “Development of targeted hormone-dependent cancer therapy”.